Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $511,400 - $576,920
-2,000 Reduced 68.97%
900 $15,000
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $590,355 - $732,942
2,700 Added 1350.0%
2,900 $18,000
Q2 2023

Jul 18, 2023

SELL
$214.27 - $253.37 $235,697 - $278,707
-1,100 Reduced 84.62%
200 $0
Q1 2023

May 01, 2023

SELL
$225.79 - $275.2 $112,895 - $137,600
-500 Reduced 27.78%
1,300 $4,000
Q4 2022

Feb 07, 2023

SELL
$229.03 - $291.01 $5.36 Million - $6.81 Million
-23,400 Reduced 92.86%
1,800 $10,000
Q3 2022

Oct 25, 2022

BUY
$224.46 - $253.15 $965,178 - $1.09 Million
4,300 Added 20.57%
25,200 $55,000
Q2 2022

Aug 04, 2022

SELL
$230.71 - $256.74 $6.25 Million - $6.96 Million
-27,100 Reduced 56.46%
20,900 $112,000
Q1 2022

Apr 14, 2022

BUY
$219.27 - $242.57 $5.46 Million - $6.04 Million
24,900 Added 107.79%
48,000 $293,000
Q4 2021

Jan 18, 2022

BUY
$198.88 - $227.6 $4.59 Million - $5.26 Million
23,100 New
23,100 $1.04 Million
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $679,264 - $795,840
-3,200 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$233.58 - $259.14 $490,518 - $544,194
-2,100 Reduced 39.62%
3,200 $10,000
Q3 2020

Oct 27, 2020

BUY
$234.65 - $260.95 $1.2 Million - $1.33 Million
5,100 Added 2550.0%
5,300 $19,000
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $3.57 Million - $4.74 Million
-19,600 Reduced 98.99%
200 $13,000
Q2 2019

Aug 09, 2019

BUY
$166.7 - $195.41 $3.18 Million - $3.73 Million
19,100 Added 2728.57%
19,800 $59,000
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $416,001 - $468,924
-2,300 Reduced 76.67%
700 $0
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $2.14 Million - $2.5 Million
-12,000 Reduced 80.0%
3,000 $3,000
Q4 2017

Jan 17, 2018

SELL
$168.79 - $188.59 $2.45 Million - $2.73 Million
-14,500 Reduced 49.15%
15,000 $1,000
Q3 2017

Oct 17, 2017

BUY
$167.29 - $191.0 $4.94 Million - $5.63 Million
29,500
29,500 $111,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.